Status:
COMPLETED
Monitoring Drug-induced Myocarditis (CardiTOX)
Lead Sponsor:
Groupe Hospitalier Pitie-Salpetriere
Conditions:
Myocarditis
Myocardial Failure
Eligibility:
All Genders
18+ years
Brief Summary
Several drugs and chemotherapies seem to induce myocarditis. This study investigates reports of myocarditis, including the International classification of disease ICD-10 for treatments in the World He...
Detailed Description
Several drugs and chemotherapies seem to have an impact on the myocardium and are responsible of myocarditis. Those are poorly described, due to the modification of the pharmacopeia, and the recent re...
Eligibility Criteria
Inclusion
- Case reported in the WHO's pharmacovigilance database till 25/02/2019
Exclusion
- Chronology not compatible between the drug and the toxicity
Key Trial Info
Start Date :
April 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 4 2023
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT03855982
Start Date
April 9 2019
End Date
April 4 2023
Last Update
April 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM
Paris, France, 75013